These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27886046)

  • 21. FDA's regulatory shift on tobacco control.
    Yang YT
    Prev Med; 2018 Aug; 113():153-155. PubMed ID: 29866276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
    Pfeffer D; Wigginton B; Gartner C; Morphett K
    Nicotine Tob Res; 2018 Aug; 20(9):1038-1046. PubMed ID: 29059355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cigarette Use in Veterans Seeking Mental Health and/or Substance Use Services.
    Hefner K; Rosenheck R; Merrel J; Coffman M; Valentine G; Sofuoglu M
    J Dual Diagn; 2016; 12(2):109-17. PubMed ID: 27064443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronic cigarettes and mental illness: Reviewing the evidence for help and harm among those with psychiatric and substance use disorders.
    Hefner K; Valentine G; Sofuoglu M
    Am J Addict; 2017 Jun; 26(4):306-315. PubMed ID: 28152247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine without smoke: fighting the tobacco epidemic with harm reduction.
    Beaglehole R; Bates C; Youdan B; Bonita R
    Lancet; 2019 Aug; 394(10200):718-720. PubMed ID: 31478489
    [No Abstract]   [Full Text] [Related]  

  • 26. Mental health service user and staff perspectives on tobacco addiction and smoking cessation: A meta-synthesis of published qualitative studies.
    Malone V; Harrison R; Daker-White G
    J Psychiatr Ment Health Nurs; 2018 May; 25(4):270-282. PubMed ID: 29498459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness.
    Collins SE; Nelson LA; Stanton J; Mayberry N; Ubay T; Taylor EM; Hoffmann G; Goldstein SC; Saxon AJ; Malone DK; Clifasefi SL; Okuyemi K;
    Subst Abus; 2019; 40(2):229-239. PubMed ID: 30924732
    [No Abstract]   [Full Text] [Related]  

  • 28. Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.
    Das S; Prochaska JJ
    Expert Rev Respir Med; 2017 Oct; 11(10):841-850. PubMed ID: 28756728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaping in mental health inpatient units: A qualitative study of consumer and staff views on electronic nicotine delivery systems.
    Naylor H; Howie A; Every-Palmer S
    Australas Psychiatry; 2024 Jun; 32(3):230-234. PubMed ID: 38430065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Think-Not Feel-about Tobacco Harm Reduction.
    Warner KE
    Nicotine Tob Res; 2019 Sep; 21(10):1299-1309. PubMed ID: 29718475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cigarette smoking and electronic cigarette vaping patterns as a function of e-cigarette flavourings.
    Litt MD; Duffy V; Oncken C
    Tob Control; 2016 Nov; 25(Suppl 2):ii67-ii72. PubMed ID: 27633766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YouTube as a source of quit smoking information for people living with mental illness.
    Sharma R; Lucas M; Ford P; Meurk C; Gartner CE
    Tob Control; 2016 Nov; 25(6):634-637. PubMed ID: 26758030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A qualitative study of the views about smoking, licensed cessation aids and e-cigarettes in people with schizophrenia spectrum disorders.
    Caponnetto P; Polosa R
    J Addict Dis; 2021; 39(2):152-165. PubMed ID: 33043838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia.
    Trigg J; Rich J; Williams E; Baker A; Bauld L; Borland R; Bullen C; Daglish M; Dunlop A; Gartner C; Jacka D; Lubman D; Manning V; McCrohan R; Segan C; Walker N; Bonevski B
    Drug Alcohol Rev; 2024 Jul; 43(5):1116-1131. PubMed ID: 38653554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions to reduce harm from continued tobacco use.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harm reduction in tobacco control: where do we draw the line?
    Al-Hamdani M; Manly E
    J Public Health Policy; 2022 Mar; 43(1):149-154. PubMed ID: 34997211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inequalities, harm reduction and non-combustible nicotine products: a meta-ethnography of qualitative evidence.
    Lucherini M; Hill S; Smith K
    BMC Public Health; 2020 Jun; 20(1):943. PubMed ID: 32539788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers.
    Fraser D; Borland R; Gartner C
    BMC Public Health; 2015 Oct; 15():1026. PubMed ID: 26444980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Youth perspectives on concurrent smoking and vaping: Implications for tobacco control.
    Antin TMJ; Hunt G; Kaner E; Lipperman-Kreda S
    Int J Drug Policy; 2019 Apr; 66():57-63. PubMed ID: 30703608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder.
    Lum A; Skelton E; Robinson M; Guillaumier A; Wynne O; Gartner C; Borland R; Baker A; Dunlop A; Wilkinson RB; Bonevski B
    Addict Behav; 2022 Jan; 124():107097. PubMed ID: 34536632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.